Skip to main content

and
  1. No Access

    Article

    Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption

    Functional magnetic resonance imaging (fMRI) has been widely used to gain a greater understanding of brain circuitry abnormalities in CNS disorders. fMRI has also been used to examine pharmacological modulatio...

    Pradeep J. Nathan, Geor Bakker in Psychopharmacology (2021)

  2. Article

    Open Access

    The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours

    The novel opioid receptor antagonist, GSK1421498, has been shown to attenuate reward-driven compulsive behaviours, such as stimulant drug seeking or binge eating, in animals and humans. Here, we report new dat...

    Eamonn Kelly, Stuart J. Mundell, Anna Sava, Adelheid L. Roth in Psychopharmacology (2015)

  3. Article

    Open Access

    Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans

    The orexin-hypocretin system is important for translating peripheral metabolic signals and central neuronal inputs to a diverse range of behaviors, from feeding, motivation and arousal, to sleep and wakefulnes...

    Ameera X. Patel, Sam R. Miller, Pradeep J. Nathan, Ponmani Kanakaraj in Psychopharmacology (2014)

  4. No Access

    Article

    Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects

    Black box warnings for young adults under the age of 25 years indicate that antidepressants may increase risk of suicide. While underlying mechanisms for age-related treatment effects remain unclear, vagally m...

    Andrew H. Kemp, Tim Outhred, Sasha Saunders, Andre R. Brunoni in Psychopharmacology (2014)

  5. No Access

    Article

    Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals

    Translational research implicates the mu opioid neurochemical system in hedonic processing, but its role in dissociable high-level cognitive functions is not well understood. Binge-eating represents a useful m...

    Samuel R. Chamberlain, Karin Mogg, Brendan P. Bradley, Annelize Koch in Psychopharmacology (2012)

  6. No Access

    Article

    Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants

    The loudness dependence of the auditory evoked potential (LDAEP) has been reported to be an effective non-invasive measure of central serotonergic neurotransmission. However, acute manipulations of the seroton...

    Julian G. Simmons, Pradeep J. Nathan, Gregor Berger in Psychopharmacology (2011)

  7. No Access

    Article

    Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants

    Schizophrenia is commonly associated with impairments in pre-attentive change detection, as represented by reduced mismatch negativity (MMN). While the neurochemical basis of MMN has been linked to N-methyl-d-asp...

    Sumie Leung, Rodney J. Croft, Valérie Guille, Kirsty Scholes in Psychopharmacology (2010)

  8. No Access

    Article

    Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study

    Serotonergic (SSRI) and noradrenergic (NRI) antidepressants modulate biases in emotional processing such that perceptual bias is shifted away from negative and towards positive emotional material. However, the...

    Rebecca Kerestes, Izelle Labuschagne, Rodney J. Croft in Psychopharmacology (2009)

  9. No Access

    Article

    Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls

    Schizophrenia is commonly associated with impairments in pre-attentive change detection as represented by reduced mismatch negativity (MMN). The neurochemical basis of MMN has been linked to N-methyl-d-aspartate ...

    Sumie Leung, Rodney J. Croft, Barry V. O’Neill, Pradeep J. Nathan in Psychopharmacology (2008)

  10. No Access

    Article

    High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans

    The loudness dependence of the auditory evoked Potential (LDAEP) has been suggested to be a putative marker of central serotonin function, with reported abnormalities in clinical disorders presumed to reflect ...

    Barry V. O’Neill, Rodney J. Croft, Sumie Leung, Chris Oliver in Psychopharmacology (2007)

  11. No Access

    Article

    Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects

    Schizophrenia is commonly associated with an impairment in pre-attentive change detection, as represented by reduced mismatch negativity (MMN), an auditory event related potential. While the neurochemical basi...

    Sumie Leung, Rodney J. Croft, Torsten Baldeweg, Pradeep J. Nathan in Psychopharmacology (2007)

  12. No Access

    Article

    Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans

    The Loudness Dependence of the Auditory Evoked Potential (LDAEP) has been suggested as a reliable measure of central serotonin function in humans; however, its specificity for the serotonin system remains a to...

    Barry V. O’Neill, Rodney J. Croft, Sumie Leung, Valérie Guille in Psychopharmacology (2006)

  13. No Access

    Article

    Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans

    The mesocortical dopamine system is regarded as an important modulator of working memory. While it has been established that stimulation of the D1/D2 receptor in primates can improve spatial working memory perfor...

    Kathryn A. Ellis, Mitul A. Mehta, Keith A. Wesnes, Stuart Armstrong in Psychopharmacology (2005)